This study describes the epidemiology, risk factors, therapeutic management, antifungal resistance patterns, and clinical outcomes of candidemia in hospitalized patients. It also examines predictors of 30-day mortality and factors associated with Candida albicans (CA) vs non-albicans Candida (NCA) infections.
Methods
A retrospective review was conducted at a tertiary care center in Lebanon (2017-2021). Clinical, microbiological, and treatment data were extracted from medical records. Statistical analyses were performed to identify factors associated with 30-day mortality and the occurrence of CA vs NCA species.
Results
A total of 98 candidemia episodes in 93 patients were analyzed. CA and NCA species were equally represented (50% each). Resistance was highest to fluconazole and itraconazole (7.3%). The 30-day mortality rate was 38.8%. Factors significantly associated with increased mortality included intensive care unit admission (odds ratio [OR] 7.42), chronic renal failure (OR 7.29), dialysis (OR 7.28), mechanical ventilation (OR 4.71), and central venous catheters (OR 10.91). Catheter removal was protective (OR 0.205, P = 0.002). NCA infections were associated with dyslipidemia (OR 3.33) and multiple previous hospitalizations (OR 3.65).
Conclusion
Antifungal resistance remains relatively low in this cohort; however, candidemia continues to carry a high mortality rate. Optimizing management through adherence to international guidelines and specialist oversight is essential to improve outcomes and address the diverse clinical presentations of CA and NCA infections.
{"title":"Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical review","authors":"Chadi Hage Chehade , Bassem Habr , Carine Harmouche , May Fakhoury , Nabil Chehata , Hassan Choker , Christian Haddad , Issam Daou , Zeina Bou Chebl , Racha Eid , Elie Haddad","doi":"10.1016/j.ijregi.2026.100864","DOIUrl":"10.1016/j.ijregi.2026.100864","url":null,"abstract":"<div><h3>Objectives</h3><div>This study describes the epidemiology, risk factors, therapeutic management, antifungal resistance patterns, and clinical outcomes of candidemia in hospitalized patients. It also examines predictors of 30-day mortality and factors associated with <em>Candida albicans</em> (CA) vs non-<em>albicans Candida</em> (NCA) infections.</div></div><div><h3>Methods</h3><div>A retrospective review was conducted at a tertiary care center in Lebanon (2017-2021). Clinical, microbiological, and treatment data were extracted from medical records. Statistical analyses were performed to identify factors associated with 30-day mortality and the occurrence of CA vs NCA species.</div></div><div><h3>Results</h3><div>A total of 98 candidemia episodes in 93 patients were analyzed. CA and NCA species were equally represented (50% each). Resistance was highest to fluconazole and itraconazole (7.3%). The 30-day mortality rate was 38.8%. Factors significantly associated with increased mortality included intensive care unit admission (odds ratio [OR] 7.42), chronic renal failure (OR 7.29), dialysis (OR 7.28), mechanical ventilation (OR 4.71), and central venous catheters (OR 10.91). Catheter removal was protective (OR 0.205, <em>P</em> = 0.002). NCA infections were associated with dyslipidemia (OR 3.33) and multiple previous hospitalizations (OR 3.65).</div></div><div><h3>Conclusion</h3><div>Antifungal resistance remains relatively low in this cohort; however, candidemia continues to carry a high mortality rate. Optimizing management through adherence to international guidelines and specialist oversight is essential to improve outcomes and address the diverse clinical presentations of CA and NCA infections.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100864"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147421067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
: COVID-19 outbreaks in residential facilities for the elderly can have severe consequences; however, effective preventive strategies remain under-evaluated. This study aimed to identify actionable, facility-level factors associated with outbreak size in such facilities in Okinawa, Japan.
Methods
: We conducted a questionnaire-based cross-sectional study of 78 residential facilities for the elderly that experienced confirmed COVID-19 outbreaks between April and June 2022. Facility-level data on infection-control practices, outbreak characteristics, and staff testing approaches were analyzed using negative binomial regression models to quantify factors associated with outbreak size.
Results
: Outbreaks detected via contact-based testing of staff were significantly smaller than those detected through routine staff reverse transcription polymerase chain reaction screening (adjusted relative risk [aRR]: 0.11; 95% confidence interval [CI]: 0.03-0.37). Resident mask-wearing was associated with smaller outbreak sizes (aRR: 0.40; 95% CI: 0.16-0.99). Routine screening identified only 16.7% of staff index cases despite being widely implemented, suggesting limitations in effectiveness.
Conclusions
: Risk-based, exposure-driven testing appears markedly more effective than fixed-interval screening for limiting outbreak size in residential facilities for the elderly. Implementation should consider both operational feasibility and support systems for frontline staff.
{"title":"Determinants of COVID-19 outbreak size in elderly residential facilities in Okinawa Prefecture, Japan, April to June 2022","authors":"Yining S Xu , Yusuke Shimakawa , Gerardo Chowell , Ryota Matsuyama , Tetsuharu Nagamoto , Ryosuke Omori , Takashi Nakamura , Toru Itokazu , Yoshihiro Takayama , Kenji Mizumoto","doi":"10.1016/j.ijregi.2025.100813","DOIUrl":"10.1016/j.ijregi.2025.100813","url":null,"abstract":"<div><h3>Objectives</h3><div><em>:</em> COVID-19 outbreaks in residential facilities for the elderly can have severe consequences; however, effective preventive strategies remain under-evaluated. This study aimed to identify actionable, facility-level factors associated with outbreak size in such facilities in Okinawa, Japan.</div></div><div><h3>Methods</h3><div><em>:</em> We conducted a questionnaire-based cross-sectional study of 78 residential facilities for the elderly that experienced confirmed COVID-19 outbreaks between April and June 2022. Facility-level data on infection-control practices, outbreak characteristics, and staff testing approaches were analyzed using negative binomial regression models to quantify factors associated with outbreak size.</div></div><div><h3>Results</h3><div><em>:</em> Outbreaks detected via contact-based testing of staff were significantly smaller than those detected through routine staff reverse transcription polymerase chain reaction screening (adjusted relative risk [aRR]: 0.11; 95% confidence interval [CI]: 0.03-0.37). Resident mask-wearing was associated with smaller outbreak sizes (aRR: 0.40; 95% CI: 0.16-0.99). Routine screening identified only 16.7% of staff index cases despite being widely implemented, suggesting limitations in effectiveness.</div></div><div><h3>Conclusions</h3><div><em>:</em> Risk-based, exposure-driven testing appears markedly more effective than fixed-interval screening for limiting outbreak size in residential facilities for the elderly. Implementation should consider both operational feasibility and support systems for frontline staff.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100813"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Enzyme-linked immunosorbent assay (ELISA)–based QuantiFERON-TB Gold Plus (QFT-Plus ELISA) testing is associated with manual variability and indeterminate results. The transition from QFT-Plus ELISA to chemiluminescent immunoassay (CLIA) for QuantiFERON-TB Gold Plus (QFT-Plus CLIA) testing represents a significant methodological evolution that requires comprehensive evaluation. This systematic review and meta-analysis aimed to assess method agreement, characterize systematic bias patterns, evaluate clinical concordance between DiaSorin's QFT-Plus CLIA and QIAGEN's (QFT-Plus ELISA) methodologies, and determine sources of heterogeneity across diverse populations for latent tuberculosis infection (LTBI) detection.
Methods: We searched the PubMed, Embase, and Google Scholar databases from January 2019 to January 2025 for studies comparing QFT-Plus CLIA and QFT-Plus ELISA methodologies for LTBI detection. Two reviewers independently screened the studies and assessed their quality using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. We conducted a meta-analysis of agreement measures using random-effects models, systematic bias characterization, meta-regression analysis of the sources of heterogeneity, and clinical subgroup analysis. Evidence certainty was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). The review was registered with PROSPERO (CRD420251031884).
Results: A total of 16 studies comprising 4169 participants were included. A meta-analysis of 10 studies (n = 2932) revealed a substantial overall concordance of 88.76% (95% confidence interval [CI] 83.57-93.95). Among the seven studies with complete data to calculate positive and negative agreement measures (n = 1305), the pooled positive agreement was 91.3% (95% CI 88.95-93.65) and the negative agreement was 93.89% (95% CI 92.18-95.6). The comparative analysis revealed a mean discordance rate of 6.56% (range: 0.44-16.67%), with a weighted mean directional bias of +0.2% (showing minimal overall directional preference between platforms). Significant heterogeneity was observed (I² = 95.8%, P <0.0001), and evidence certainty was rated “very low” due to methodological limitations.
Conclusions: Diasorin's QFT-Plus CLIA and QIAGEN's QFT-Plus ELISA demonstrated substantial overall agreement in detecting LTBI, with the strongest concordance for clearly positive and negative results. Laboratories implementing QFT-Plus CLIA platforms should consider verification studies, and future research should evaluate the clinical significance of discordant results and optimize interpretive algorithms for diverse epidemiologic settings.
目的:基于酶联免疫吸附试验(ELISA)的QuantiFERON-TB Gold Plus (QFT-Plus ELISA)检测与人工变异和不确定结果相关。QuantiFERON-TB Gold Plus (QFT-Plus CLIA)检测从QFT-Plus ELISA到化学发光免疫分析法(CLIA)的转变代表了一种重要的方法学进化,需要进行全面的评估。本系统综述和荟萃分析旨在评估方法的一致性,表征系统偏倚模式,评估DiaSorin的QFT-Plus CLIA和QIAGEN的QFT-Plus ELISA方法之间的临床一致性,并确定不同人群中潜伏性结核感染(LTBI)检测的异质性来源。方法:我们检索了2019年1月至2025年1月的PubMed、Embase和谷歌Scholar数据库,以比较QFT-Plus CLIA和QFT-Plus ELISA方法检测LTBI的研究。两名审稿人独立筛选研究并使用诊断准确性研究质量评估2 (QUADAS-2)工具评估其质量。我们使用随机效应模型、系统偏倚表征、异质性来源的元回归分析和临床亚组分析对一致性测量进行了荟萃分析。证据确定性采用推荐、评估、发展和评价分级(GRADE)进行评估。该综述已在PROSPERO注册(CRD420251031884)。结果:共纳入16项研究,4169名受试者。10项研究(n = 2932)的荟萃分析显示,总体一致性为88.76%(95%可信区间[CI] 83.57-93.95)。在有完整资料计算阳性和阴性一致性测度的7项研究(n = 1305)中,阳性一致性为91.3% (95% CI 88.95-93.65),阴性一致性为93.89% (95% CI 92.18-95.6)。对比分析显示,平均不一致率为6.56%(范围:0.44-16.67%),加权平均方向偏差为+0.2%(平台之间的总体方向偏好最小)。观察到显著的异质性(I²= 95.8%,P <0.0001),由于方法学的限制,证据确定性被评为“非常低”。结论:Diasorin的QFT-Plus CLIA和QIAGEN的QFT-Plus ELISA在检测LTBI方面显示出大量的总体一致性,在明确的阳性和阴性结果方面具有最强的一致性。实施QFT-Plus CLIA平台的实验室应考虑验证研究,未来的研究应评估不一致结果的临床意义,并优化不同流行病学背景下的解释算法。
{"title":"Agreement and systematic bias between QuantiFERON chemiluminescent immunoassay and QuantiFERON enzyme-linked immunosorbent assay in the detection of latent tuberculosis infection: A systematic review and meta-analysis","authors":"Felix Bongomin , Ivaan Pitua , Phillip Ssekamatte , Diana Sitenda , Irene Andia-Biraro , Bwambale Jonani","doi":"10.1016/j.ijregi.2025.100824","DOIUrl":"10.1016/j.ijregi.2025.100824","url":null,"abstract":"<div><div>Objectives: Enzyme-linked immunosorbent assay (ELISA)–based QuantiFERON-TB Gold Plus (QFT-Plus ELISA) testing is associated with manual variability and indeterminate results. The transition from QFT-Plus ELISA to chemiluminescent immunoassay (CLIA) for QuantiFERON-TB Gold Plus (QFT-Plus CLIA) testing represents a significant methodological evolution that requires comprehensive evaluation. This systematic review and meta-analysis aimed to assess method agreement, characterize systematic bias patterns, evaluate clinical concordance between DiaSorin's QFT-Plus CLIA and QIAGEN's (QFT-Plus ELISA) methodologies, and determine sources of heterogeneity across diverse populations for latent tuberculosis infection (LTBI) detection.</div><div>Methods: We searched the PubMed, Embase, and Google Scholar databases from January 2019 to January 2025 for studies comparing QFT-Plus CLIA and QFT-Plus ELISA methodologies for LTBI detection. Two reviewers independently screened the studies and assessed their quality using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. We conducted a meta-analysis of agreement measures using random-effects models, systematic bias characterization, meta-regression analysis of the sources of heterogeneity, and clinical subgroup analysis. Evidence certainty was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). The review was registered with PROSPERO (CRD420251031884).</div><div>Results: A total of 16 studies comprising 4169 participants were included. A meta-analysis of 10 studies (n = 2932) revealed a substantial overall concordance of 88.76% (95% confidence interval [CI] 83.57-93.95). Among the seven studies with complete data to calculate positive and negative agreement measures (n = 1305), the pooled positive agreement was 91.3% (95% CI 88.95-93.65) and the negative agreement was 93.89% (95% CI 92.18-95.6). The comparative analysis revealed a mean discordance rate of 6.56% (range: 0.44-16.67%), with a weighted mean directional bias of +0.2% (showing minimal overall directional preference between platforms). Significant heterogeneity was observed (I² = 95.8%, <em>P</em> <0.0001), and evidence certainty was rated “very low” due to methodological limitations.</div><div>Conclusions: Diasorin's QFT-Plus CLIA and QIAGEN's QFT-Plus ELISA demonstrated substantial overall agreement in detecting LTBI, with the strongest concordance for clearly positive and negative results. Laboratories implementing QFT-Plus CLIA platforms should consider verification studies, and future research should evaluate the clinical significance of discordant results and optimize interpretive algorithms for diverse epidemiologic settings.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100824"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-12DOI: 10.1016/j.ijregi.2026.100844
Xuan Duong Tran , Thi Loi Dao , Ndiaw Goumballa , Trong Kiem Tran , Thanh Binh Nguyen , Duy Cuong Nguyen , Pierre Marty , Philippe Gautret
Objectives
This study aimed to assess the prevalence of multidrug-resistant (MDR) bacterial carriage and resistance-encoding genes in children with acute diarrhea.
Methods
A prospective study was conducted from July 2020 to July 2021 in hospitalized children aged under 5 years. Stool samples were collected at hospital admission. MDR bacteria were identified by culture, antimicrobial susceptibility patterns were assessed using the disk diffusion method, and resistance genes were investigated in isolates, using real-time polymerase chain reaction. Colistin resistance genes were also tested from stool samples.
Results
A total of 451 children were included; 33.2% harbored at least one MDR bacteria and/or one colistin resistance genes. A total of 79 (17.6%) children were positive for at least one MDR pathogen by culture. A total of 100 isolates were identified, including 17 methicillin-resistant Staphylococcus aureus and 83 Enterobacteriaceae. Escherichia coli was the most common (11.8%), followed by S. aureus (3.8%) and Klebsiella pneumoniae (2.7%). High resistance levels were observed in tested isolates: 94.8% to ceftriaxone, 77.1% to cefepime, 42.2% to piperacillin–tazobactam, and 19.3% to ertapenem. Among methicillin-resistant S. aureus isolates, 15 of 17 (88.2%) carried the mecA gene. Among Enterobacteriaceae, 73/83 (88.0%) carried blaCTX-M-A, 49 (59.0%) had blaTEM, 19 (22.9%) had blaSHV, and six (7.2%) were positive for blaNDM. In addition, 87 (19.3%) of 451 children carried at least one colistin resistance gene, with 10.9% of mcr-1.
Conclusions
MDR bacterial carriage and resistance genes were frequently detected at hospital admission, reflecting community or previous health care–associated exposure rather than in-hospital antibiotic selection. These findings underscore the urgent need for strengthened antimicrobial stewardship, rational antibiotic use, improved infection control, and enhanced diagnostic capacity.
{"title":"Carriage of multidrug-resistant bacteria and encoding genes among Vietnamese children with acute diarrhea","authors":"Xuan Duong Tran , Thi Loi Dao , Ndiaw Goumballa , Trong Kiem Tran , Thanh Binh Nguyen , Duy Cuong Nguyen , Pierre Marty , Philippe Gautret","doi":"10.1016/j.ijregi.2026.100844","DOIUrl":"10.1016/j.ijregi.2026.100844","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to assess the prevalence of multidrug-resistant (MDR) bacterial carriage and resistance-encoding genes in children with acute diarrhea.</div></div><div><h3>Methods</h3><div>A prospective study was conducted from July 2020 to July 2021 in hospitalized children aged under 5 years. Stool samples were collected at hospital admission. MDR bacteria were identified by culture, antimicrobial susceptibility patterns were assessed using the disk diffusion method, and resistance genes were investigated in isolates, using real-time polymerase chain reaction. Colistin resistance genes were also tested from stool samples.</div></div><div><h3>Results</h3><div>A total of 451 children were included; 33.2% harbored at least one MDR bacteria and/or one colistin resistance genes. A total of 79 (17.6%) children were positive for at least one MDR pathogen by culture. A total of 100 isolates were identified, including 17 methicillin-resistant <em>Staphylococcus aureus</em> and 83 Enterobacteriaceae. <em>Escherichia coli</em> was the most common (11.8%), followed by <em>S. aureus</em> (3.8%) and <em>Klebsiella pneumoniae</em> (2.7%). High resistance levels were observed in tested isolates: 94.8% to ceftriaxone, 77.1% to cefepime, 42.2% to piperacillin–tazobactam, and 19.3% to ertapenem. Among methicillin-resistant <em>S. aureus</em> isolates, 15 of 17 (88.2%) carried the <em>mecA</em> gene. Among Enterobacteriaceae, 73/83 (88.0%) carried <em>bla<sub>CTX-M-A</sub></em>, 49 (59.0%) had <em>bla<sub>TEM</sub></em>, 19 (22.9%) had <em>bla<sub>SHV</sub></em>, and six (7.2%) were positive for <em>bla<sub>NDM</sub></em>. In addition, 87 (19.3%) of 451 children carried at least one colistin resistance gene, with 10.9% of <em>mcr-1</em>.</div></div><div><h3>Conclusions</h3><div>MDR bacterial carriage and resistance genes were frequently detected at hospital admission, reflecting community or previous health care–associated exposure rather than in-hospital antibiotic selection. These findings underscore the urgent need for strengthened antimicrobial stewardship, rational antibiotic use, improved infection control, and enhanced diagnostic capacity.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100844"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The increasing burden of extensively drug-resistant tuberculosis (XDR-TB) undermines global TB control efforts.
Methods
This was a case series study conducted from January 1, 2007, to December 31, 2024, in the Department of Pulmonology at Sylvanus Olympio University Teaching Hospital.
Results
We report a series of three cases. Case 1: A 30-year-old man with a history of contact with an XDR-TB case was treated with a 20-month regimen. Culture conversion was achieved at the 3rd month of treatment. A complication in the form of pyopneumothorax occurred during the 6th month of therapy. Case 2: A 51-year-old patient with no significant medical history was diagnosed with XDR-TB after 4 months of treatment for multidrug-resistant TB (MDR-TB). Conversion of follow-up cultures was achieved 2 months after modification of the treatment regimen. Case 3: A 62-year-old woman living with human immunodeficiency virus (HIV), previously treated for MDR-TB, developed XDR-TB during the course of treatment. The patient died on the 29th day of XDR-TB treatment.
Conclusions
XDR-TB is a curable disease. Early and accurate diagnosis allows for better selection of the most appropriate treatment strategy.
{"title":"Extensively drug-resistant tuberculosis in Togo: first reported cases and implications for tuberculosis control","authors":"Maïssala Zoutené , Akouvi Mawussé Edjodjinam Ako , Koffi Atsu Aziagbe , Narcisse Viani Gateu Tadjom , Tété Amento Stéphane Adambounou , Komi Séraphin Adjoh","doi":"10.1016/j.ijregi.2025.100825","DOIUrl":"10.1016/j.ijregi.2025.100825","url":null,"abstract":"<div><h3>Objectives</h3><div>The increasing burden of extensively drug-resistant tuberculosis (XDR-TB) undermines global TB control efforts.</div></div><div><h3>Methods</h3><div>This was a case series study conducted from January 1, 2007, to December 31, 2024, in the Department of Pulmonology at Sylvanus Olympio University Teaching Hospital.</div></div><div><h3>Results</h3><div>We report a series of three cases. Case 1: A 30-year-old man with a history of contact with an XDR-TB case was treated with a 20-month regimen. Culture conversion was achieved at the 3<sup>rd</sup> month of treatment. A complication in the form of pyopneumothorax occurred during the 6<sup>th</sup> month of therapy. Case 2: A 51-year-old patient with no significant medical history was diagnosed with XDR-TB after 4 months of treatment for multidrug-resistant TB (MDR-TB). Conversion of follow-up cultures was achieved 2 months after modification of the treatment regimen. Case 3: A 62-year-old woman living with human immunodeficiency virus (HIV), previously treated for MDR-TB, developed XDR-TB during the course of treatment. The patient died on the 29th day of XDR-TB treatment.</div></div><div><h3>Conclusions</h3><div>XDR-TB is a curable disease. Early and accurate diagnosis allows for better selection of the most appropriate treatment strategy.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100825"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-18DOI: 10.1016/j.ijregi.2026.100848
Shubhada Hooli , Beatwil Zadutsa , Everlisto Phiri , Karina Hofstee , Nichole Davis , Eric D. McCollum , Charles Makwenda , Carina King
Objectives
We sought to understand barriers to high-quality hospital-based child acute lower respiratory infection (ALRI) care at Mchinji District Hospital in Malawi.
Methods
In 2020, we conducted focus group discussions (FGDs) with clinical officers (COs) who provided direct clinical care after a half-day refresher course on pediatric ALRI case management. The underpinning research methodology of the FGDs was phenomenology, and they were analyzed using inductive and deductive thematic analysis.
Results
We recruited 16 COs to participate in three FGDs. Five themes emerged: lack of confidence in ALRI diagnosis and management, high clinical burden with understaffing, dysfunctional team dynamics, limited physical resources, and the recognition of the importance of vital sign measurements despite barriers to practice.
Conclusions
COs shared several barriers and potential interventions to improve child ALRI care delivery. Some solutions were locally implementable, with minimal to modest cost, such as a program for continuing education, standard operating procedures during electricity outages, and posting of job aides. However, many of their suggestions require investments and commitment from the Malawian Ministry of Health to increase staffing capacity and improve the physical infrastructure and are, therefore, of undetermined feasibility. Future research should examine the impact of hospital layout and infrastructure, continuing education programs, and informal vital sign assistants on clinical care delivery.
{"title":"Health care worker–reported barriers and potential facilitators of acute lower respiratory infection care deliver for children at Mchinji District Hospital in Malawi","authors":"Shubhada Hooli , Beatwil Zadutsa , Everlisto Phiri , Karina Hofstee , Nichole Davis , Eric D. McCollum , Charles Makwenda , Carina King","doi":"10.1016/j.ijregi.2026.100848","DOIUrl":"10.1016/j.ijregi.2026.100848","url":null,"abstract":"<div><h3>Objectives</h3><div>We sought to understand barriers to high-quality hospital-based child acute lower respiratory infection (ALRI) care at Mchinji District Hospital in Malawi.</div></div><div><h3>Methods</h3><div>In 2020, we conducted focus group discussions (FGDs) with clinical officers (COs) who provided direct clinical care after a half-day refresher course on pediatric ALRI case management. The underpinning research methodology of the FGDs was phenomenology, and they were analyzed using inductive and deductive thematic analysis.</div></div><div><h3>Results</h3><div>We recruited 16 COs to participate in three FGDs. Five themes emerged: lack of confidence in ALRI diagnosis and management, high clinical burden with understaffing, dysfunctional team dynamics, limited physical resources, and the recognition of the importance of vital sign measurements despite barriers to practice.</div></div><div><h3>Conclusions</h3><div>COs shared several barriers and potential interventions to improve child ALRI care delivery. Some solutions were locally implementable, with minimal to modest cost, such as a program for continuing education, standard operating procedures during electricity outages, and posting of job aides. However, many of their suggestions require investments and commitment from the Malawian Ministry of Health to increase staffing capacity and improve the physical infrastructure and are, therefore, of undetermined feasibility. Future research should examine the impact of hospital layout and infrastructure, continuing education programs, and informal vital sign assistants on clinical care delivery.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100848"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-08DOI: 10.1016/j.ijregi.2026.100840
Karel Santamaria-Leandro , Bruno Guerrero-Arismendiz , César Castro-Prado , Giancarlo Pérez-Lazo , Wilmer Silva-Caso
Objectives
Cystic echinococcosis (CE) rarely coexists with hematologic malignancies. We report two Peruvian men with leukemia and CE.
Case report
One patient had chronic lymphocytic leukemia and a hepatic CE2 cyst managed with albendazole and surgery before chemoimmunotherapy, and another patient had B-cell acute lymphoblastic leukemia and prior hepatic and pulmonary CE treated with concurrent albendazole and induction chemotherapy. Both patients lived in endemic highland areas and had childhood exposure to dogs.
Discussion
A literature review identified only a few cases, mostly acute myeloid leukemia, and none from Latin America.
Conclusion
These cases highlight therapeutic dilemmas in balancing infection control and malignancy treatment, underscoring the need for tailored management strategies in endemic regions.
{"title":"Cystic echinococcosis in patients with leukemia: Clinical challenges and review of reported cases","authors":"Karel Santamaria-Leandro , Bruno Guerrero-Arismendiz , César Castro-Prado , Giancarlo Pérez-Lazo , Wilmer Silva-Caso","doi":"10.1016/j.ijregi.2026.100840","DOIUrl":"10.1016/j.ijregi.2026.100840","url":null,"abstract":"<div><h3>Objectives</h3><div>Cystic echinococcosis (CE) rarely coexists with hematologic malignancies. We report two Peruvian men with leukemia and CE.</div></div><div><h3>Case report</h3><div>One patient had chronic lymphocytic leukemia and a hepatic CE2 cyst managed with albendazole and surgery before chemoimmunotherapy, and another patient had B-cell acute lymphoblastic leukemia and prior hepatic and pulmonary CE treated with concurrent albendazole and induction chemotherapy. Both patients lived in endemic highland areas and had childhood exposure to dogs.</div></div><div><h3>Discussion</h3><div>A literature review identified only a few cases, mostly acute myeloid leukemia, and none from Latin America.</div></div><div><h3>Conclusion</h3><div>These cases highlight therapeutic dilemmas in balancing infection control and malignancy treatment, underscoring the need for tailored management strategies in endemic regions.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100840"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To report a case of chorioretinitis without papilledema caused by Bartonella henselae in an immunocompetent patient.
Observations
A 27-year-old female patient with a history of multiple cat scratches presented on August 28, 2025, with a gradual decline in visual acuity in her right eye. This decline had been developing for 3 weeks following scratches from cats and was accompanied by a fever of 39°C. Optical coherence tomography revealed serous retinal detachment with associated epithelial detachment. Fluorescein angiography showed a hyperfluorescent perimacular focus in the superior temporal region, consistent with chorioretinitis characterized by star-shaped macular exudates, and there was no evidence of papilledema. HIV-1 and 2 serology was negative. Serum protein electrophoresis returned normal results, and the HbA1c level was 5.5%. Serology for B. henselae was positive (immunoglobulin [Ig]G and IgM) with titers greater than 1:1280 and 1:1200. The treatment plan included doxycycline (100 mg every 12 hours) for 6 weeks and rifampicin (300 mg every 12 hours) with corticosteroid therapy (1 mg/kg) for 4 weeks. Fluorescein angiography conducted 6 weeks after treatment showed a hypofluorescent area in the superior temporal region of the macula, indicating that the star-shaped macular exudates had disappeared. The patient reported improved visual acuity, although they experienced slight blurred vision in the right eye.
Conclusions
Ocular bartonellosis can lead to unusual eye damage, specifically chorioretinitis, even in the absence of papilledema.
{"title":"Atypical ocular bartonellosis: A case report","authors":"Kamena Mwana-Yile HASSAN , Fatima IHBIBANE , Mathilde OTSASSO , Latifa MARIH","doi":"10.1016/j.ijregi.2025.100830","DOIUrl":"10.1016/j.ijregi.2025.100830","url":null,"abstract":"<div><h3>Objectives</h3><div>To report a case of chorioretinitis without papilledema caused by <em>Bartonella henselae</em> in an immunocompetent patient.</div></div><div><h3>Observations</h3><div>A 27-year-old female patient with a history of multiple cat scratches presented on August 28, 2025, with a gradual decline in visual acuity in her right eye. This decline had been developing for 3 weeks following scratches from cats and was accompanied by a fever of 39°C. Optical coherence tomography revealed serous retinal detachment with associated epithelial detachment. Fluorescein angiography showed a hyperfluorescent perimacular focus in the superior temporal region, consistent with chorioretinitis characterized by star-shaped macular exudates, and there was no evidence of papilledema. HIV-1 and 2 serology was negative. Serum protein electrophoresis returned normal results, and the HbA1c level was 5.5%. Serology for <em>B. henselae</em> was positive (immunoglobulin [Ig]G and IgM) with titers greater than 1:1280 and 1:1200. The treatment plan included doxycycline (100 mg every 12 hours) for 6 weeks and rifampicin (300 mg every 12 hours) with corticosteroid therapy (1 mg/kg) for 4 weeks. Fluorescein angiography conducted 6 weeks after treatment showed a hypofluorescent area in the superior temporal region of the macula, indicating that the star-shaped macular exudates had disappeared. The patient reported improved visual acuity, although they experienced slight blurred vision in the right eye.</div></div><div><h3>Conclusions</h3><div>Ocular bartonellosis can lead to unusual eye damage, specifically chorioretinitis, even in the absence of papilledema.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100830"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cameroon is known to be endemic for hepatitis B virus infection, but available data on hepatitis delta virus (HDV) prevalence and genetic diversity are limited, inconsistent, and outdated. This study aimed to assess the current HDV prevalence and determine the HDV genotype distribution among patients positive for hepatitis B surface antigen (HBsAg) in Cameroon.
Methods
This cross-sectional study examined patients positive for HBsAg from Cameroon’s 10 administrative regions. Anti-HDV antibodies and HDV viral load (VL) were tested using validated commercial enzyme-linked immunosorbent assay and HDV VL quantification assays. HDV genotypes were determined by the Sanger sequencing method, followed by phylogenetic analysis of the “HDV R0” genome region previously described.
Results
Of the 859 patients positive for HBsAg tested, 142 (16.5%) tested positive for anti-HDV, and HDV RNA was detected in 110 (77.5%) of them. The southern region of Cameroon had the highest infection rate. Notably, an undetectable hepatitis B virus VL was significantly associated with HDV infection (P <0.001). Patients younger than 15 years were the least infected (10%). Five genotypes—HDV-1 (the more prevalent, 83.6%), HDV-5, HDV-6, HDV-7, and HDV-8—were found in the studied population.
Conclusions
Cameroon remains an endemic country for HDV, exhibiting high prevalence, remarkable regional distribution, and wide genetic diversity.
{"title":"Update on the HDV seroprevalence and genotype distribution among patients positive for HBsAg referred to a National Reference Laboratory in Cameroon between January 2019 and December 2020","authors":"Jacques Delors Toumansie Mfonkou , Yacouba Foupouapouognigni , Athenais Gerber , Ségolène Brichler , Frédéric Legal , Abdou Fatawou Modiyinji , Frederic Lissock , Laure Ngono , Boyomo Onana , Emmanuel Gordien , Richard Njouom","doi":"10.1016/j.ijregi.2025.100834","DOIUrl":"10.1016/j.ijregi.2025.100834","url":null,"abstract":"<div><h3>Objectives</h3><div>Cameroon is known to be endemic for hepatitis B virus infection, but available data on hepatitis delta virus (HDV) prevalence and genetic diversity are limited, inconsistent, and outdated. This study aimed to assess the current HDV prevalence and determine the HDV genotype distribution among patients positive for hepatitis B surface antigen (HBsAg) in Cameroon.</div></div><div><h3>Methods</h3><div>This cross-sectional study examined patients positive for HBsAg from Cameroon’s 10 administrative regions. Anti-HDV antibodies and HDV viral load (VL) were tested using validated commercial enzyme-linked immunosorbent assay and HDV VL quantification assays. HDV genotypes were determined by the Sanger sequencing method, followed by phylogenetic analysis of the “HDV R0” genome region previously described.</div></div><div><h3>Results</h3><div>Of the 859 patients positive for HBsAg tested, 142 (16.5%) tested positive for anti-HDV, and HDV RNA was detected in 110 (77.5%) of them. The southern region of Cameroon had the highest infection rate. Notably, an undetectable hepatitis B virus VL was significantly associated with HDV infection (<em>P</em> <0.001). Patients younger than 15 years were the least infected (10%). Five genotypes—HDV-1 (the more prevalent, 83.6%), HDV-5, HDV-6, HDV-7, and HDV-8—were found in the studied population.</div></div><div><h3>Conclusions</h3><div>Cameroon remains an endemic country for HDV, exhibiting high prevalence, remarkable regional distribution, and wide genetic diversity.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100834"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}